Geographic isolates of atypical Parkinsonism and tauopathy in the tropics: Possible synergy of neurotoxins

Movement Disorders

Volumn 21, Issue 10, 2006, Pages 1769-1771

  Caparros Lefebvre, Dominique ^a   Steele, John ^b   Kotake, Yaichiro ^c   Ohta, Shigeru ^c  

^a CENTRE HOSPITALIER DE VALENCIENNES   (France)

^b Micronesian Health Study II ^*  (Guam)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Annonaceae acetogenins; Atypical Parkinsonism; Guadeloupe; Guam; Rotenone

Indexed keywords

ACETOGENIN; ANNONACIN; NEUROTOXIN; ROTENONE;

AMYOTROPHIC LATERAL SCLEROSIS; ANNONACEAE; ARTICLE; BRAIN NERVE CELL; DEMENTIA; DIFFERENTIAL DIAGNOSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GEOGRAPHIC DISTRIBUTION; GUADELOUPE; GUAM; HUMAN; NEUROTOXICITY; NEW CALEDONIA; PAPUA NEW GUINEA; PARKINSONISM; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; TAUOPATHY; TROPICS;

AMINO ACIDS, DIAMINO; ANNONACEAE; DRUG SYNERGISM; FATTY ALCOHOLS; GUADELOUPE; GUAM; HUMANS; JAPAN; LACTONES; MOTOR NEURON DISEASE; NEUROTOXINS; PARKINSON DISEASE, SECONDARY; ROTENONE; TAUOPATHIES; TROPICAL CLIMATE;

EID: 33750997859     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21024     Document Type: Article

References (25)

1. Caparros-Lefebvre D, Elbaz A, and the Caribbean Parkinsonism Study group. Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Lancet 1999;354:281-286.
2. Angibaud G, Gaultier C, Rascol O. Atypical parkinsonism and Annonaceae consumption. Mov Disord 2004;19:603-604.
3. Caparros-Lefebvre D. Atypical parkinsonism in New Caledonia: comparison with Guadeloupe and association with Annonaceae consumption. Mov Disord 2004;19:604.
4. Höglinger GU, Michel PP, Champy P, et al. Experimental evidence for a toxic etiology of tropical parkinsonism. Mov Disord 2005; 20:118-119.
5. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983;219:979-998.
6. Höglinger GU, Feger J, Prigent A, et al. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J Neurochem 2003;84:491-502.
7. Caparros-Lefebvre D, Sergeant N, Lees A, et al. Guadeloupean parkinsonism: a cluster of PSP-like tauopathy. Brain 2002;125: 801-811.
8. Steele JC, Caparros-Lefebvre D, Lees AJ, Sacks OW. Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism. Parkinsonism Relat Disord 2002;9:39-54.
9. Kuzuhara S, Kokuba Y, Sasaki R, et al. Familial amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Kii Peninsula of Japan: clinical and neuropathological study and tau analysis. Ann Neurol 2000;49:501-511.
10. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum, with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-359.
11. Plato CC, Garruto RM, Galasko D, et al. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years. Am J Epidemiol 2003; 157:149-157.
12. Hirano A, Malamud N, Kurland LT. Parkinsonism-dementia complex, an endemic disease on the island of Guam. II. Pathological features. Brain 1961;84:662-679.
13. Geddes JF, Hughes AJ, Lees AJ, Daniel SE. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles. A study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex. Brain 1993; 116:281-302.
14. von Economo, C. Encephalitis Lediargica: Its Sequelae and Treatment. Translated by K. O. Newman. Humphrey Milford, London: Oxford University Press; 1931.
15. Zimmerman H. Progress report of work in the laboratory of pathology during May, 1945. Guam. Washington, DC: US Naval Medical Research Unit; 1945.
16. Monmaney T. Annals of science: this obscure malady. The New Yorker; 1990. p 85-113.
17. Sacks OW. The island of the colorblind. New York: Alfred A. Knopf; 1997.
18. Wiener J. Annals of medicine: the tangle. Searching for the cause of a brain disease. The New Yorker; 2005. p 42-51.
19. Spencer PS, Nunn PB, Hugon J, et al. Guam amyotrophic lateral sclerosis Parkinsonism dementia linked to a plant excitotoxin. Science 1987;237:517-522.
20. Murch SJ, Cox PA, Banack SA. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc Natl Acad Sci U S A 2004;101:12228-12231.
21. Caparros-Lefebvre D, Steele J. Atypical parkinsonism on Guadeloupe, comparison with Guam and environmental toxic hypotheses. Environ Toxicol Pharmacol 2005;19:407-413.
22. Caboni P, Sherer TB, Zhang N, et al. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease. Chem Res Toxicol 2004;17:1540-1548.
23. Höglinger GU, Lannuzel A, Escobar Khondiker M, et al. The mitachondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J Neurochem 2005;95:930-939.
24. Fournet J. Flore illustrée des phanérogames de Guadeloupe et de Martinique. Gondwana editions, Cirad, Montpellier, France. 2002.
25. Chen CY, Chang FR, Chiu HF, Wu MJ, Wu YC. Aromine-A, an Annonaceous acetogenin from Annona cherimola. Phytochemistry 1999;51:429-433.